|
1
|
Gu X, Gong H, Shen L and Gu Q:
MicroRNA-129-5p inhibits human glioma cell proliferation and
induces cell cycle arrest by directly targeting DNMT3A. Am J Transl
Res. 10:2834–2847. 2018.PubMed/NCBI
|
|
2
|
Ji ZG, Jiang HT and Zhang PS: FOXK1
promotes cell growth through activating wnt/β-catenin pathway and
emerges as a novel target of miR-137 in glioma. Am J Transl Res.
10:1784–1792. 2018.PubMed/NCBI
|
|
3
|
Gao Y, Lin L, Li T, Yang J and Wei Y: The
role of miRNA-223 in cancer: Function, diagnosis and therapy. Gene.
616:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang F, Liang S, Liu X, Han L, Wang J and
Du Q: LINC00460 modulates KDM2A to promote cell proliferation and
migration by targeting miR-342-3p in gastric cancer. Onco Targets
Ther. 11:6383–6394. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu W, Kang L, Han J, Wang Y, Shen C, Yan
Z, Tai Y and Zhao C: miR-342-3p suppresses hepatocellular carcinoma
proliferation through inhibition of IGF-1R-mediated Warburg effect.
Onco Targets Ther. 11:1643–1653. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xue X, Fei X, Hou W, Zhang Y, Liu L and Hu
R: miR-342-3p suppresses cell proliferation and migration by
targeting AGR2 in non-small cell lung cancer. Cancer Lett.
412:170–178. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Venkatakrishnan AJ, Deupi X, Lebon G, Tate
CG, Schertler GF and Babu MM: Molecular signatures of
G-protein-coupled receptors. Nature. 494:185–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Solinski HJ, Gudermann T and Breit A:
Pharmacology and signaling of MAS-related G protein-coupled
receptors. Pharmacol Rev. 66:570–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jin E, Wang W, Fang M, Wang W, Xie R, Zhou
H, Ye J, Xu R and Ma S: Clinical significance of reduced GPRC5A
expression in surgically resected non-small cell lung cancer. Oncol
Lett. 17:502–507. 2019.PubMed/NCBI
|
|
10
|
Gu C, Zhou N, Wang Z, Li G, Kou Y, Yu S,
Feng Y, Chen L, Yang J and Tian F: circGprc5a promoted bladder
oncogenesis and metastasis through Gprc5a-targeting peptide. Mol
Ther Nucleic Acids. 13:633–641. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Klaschik K, Hauke J, Neidhardt G, Tränkle
C, Surowy HM, Heilmann-Heimbach S, Rappl G, Mangold E, Arnold N,
Niederacher D, et al: The GPRC5A frameshift variant c.183del is not
associated with increased breast cancer risk in BRCA1 mutation
carriers. Int J Cancer. 144:1761–1763. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jing L, Li H, Zhang T, Lu J and Zhong L:
MicroRNA-4530 suppresses cell proliferation and induces apoptosis
by targeting RASA1 in human umbilical vein endothelial cells. Mol
Med Rep. 19:3393–3402. 2019.PubMed/NCBI
|
|
13
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang H, Tang C, Na M, Ma W, Jiang Z, Gu Y,
Ma G, Ge H, Shen H and Lin Z: miR-422a inhibits glioma
proliferation and invasion by targeting IGF1 and IGF1R. Oncol Res.
25:187–194. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhi T, Jiang K, Xu X, Yu T, Wu W, Nie E,
Zhou X, Jin X, Zhang J, Wang Y and Liu N: MicroRNA-520d-5p inhibits
human glioma cell proliferation and induces cell cycle arrest by
directly targeting PTTG1. Am J Transl Res. 9:4872–4887.
2017.PubMed/NCBI
|
|
16
|
Gu G, Wang L, Zhang J, Wang H, Tan T and
Zhang G: MicroRNA-384 inhibits proliferation migration and invasion
of glioma by targeting at CDC42. Onco Targets Ther. 11:4075–4085.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma J, Yu J, Liu J, Yang X, Lou M, Liu J,
Feng F, Ji P and Wang L: MicroRNA-302a targets GAB2 to suppress
cell proliferation, migration and invasion of glioma. Oncol Rep.
37:1159–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Romero-Cordoba SL, Rodriguez-Cuevas S,
Bautista-Pina V, Maffuz-Aziz A, D'Ippolito E, Cosentino G, Baroni
S, Iorio MV and Hidalgo-Miranda A: Loss of function of miR-342-3p
results in MCT1 over-expression and contributes to oncogenic
metabolic reprogramming in triple negative breast cancer. Sci Rep.
8:122522018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu K, Mu X, Kolibaba H, Yin Q, Liu C,
Liang X and Lu J: Metadherin is an apoptotic modulator in prostate
cancer through miR-342-3p regulation. Saudi J Biol Sci. 25:975–981.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu X, Li W, Zhang R and Liu Y:
MicroRNA-342 inhibits cell proliferation and invasion in
nasopharyngeal carcinoma by directly targeting ZEB1. Oncol Lett.
16:1298–1304. 2018.PubMed/NCBI
|
|
21
|
Gentry PR, Sexton PM and Christopoulos A:
Novel allosteric modulators of G protein-coupled receptors. J Biol
Chem. 290:19478–19488. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scholz N, Gehring J, Guan C, Ljaschenko D,
Fischer R, Lakshmanan V, Kittel RJ and Langenhan T: The adhesion
GPCR latrophilin/CIRL shapes mechanosensation. Cell Rep.
11:866–874. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ferré S, Casadó V, Devi LA, Filizola M,
Jockers R, Lohse MJ, Milligan G, Pin JP and Guitart X: G
protein-coupled receptor oligomerization revisited: functional and
pharmacological perspectives. Pharmacol Rev. 66:413–434. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kumari P, Ghosh E and Shukla AK: Emerging
approaches to GPCR ligand screening for drug discovery. Trends Mol
Med. 21:687–701. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kadara H, Fujimoto J, Men T, Ye X, Lotan
D, Lee JS and Lotan R: A Gprc5a tumor suppressor loss of expression
signature is conserved, prevalent, and associated with survival in
human lung adenocarcinomas. Neoplasia. 12:499–505. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu S, Ye D, Wang T, Guo W, Song H, Liao
Y, Xu D, Zhu H, Zhang Z and Deng J: Repression of GPRC5A is
associated with activated STAT3, which contributes to tumor
progression of head and neck squamous cell carcinoma. Cancer Cell
Int. 17:342017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou H and Rigoutsos I: The emerging roles
of GPRC5A in diseases. Oncoscience. 1:765–776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou H and Rigoutsos I: MiR-103a-3p
targets the 5′UTR of GPRC5A in pancreatic cells. RNA. 20:1431–1439.
2014. View Article : Google Scholar : PubMed/NCBI
|
